Preparations for buy-side clearing of OTC derivatives falling behind schedule

The move to central clearing of OTC derivatives is meant to reduce systemic risk. It also creates plenty of headaches for the buy-side. Some hedge funds may not be ready before the March deadline.

clearing and settlement

Change is always disruptive and the move to central clearing of over-the-counter derivatives is no exception.

Few expected a smooth ride. But with only weeks to go before the reforms come into force in the US, the buy-side is still in the dark about a range of issues. Preparations for clearing have fallen behind schedule.

On November 28 last year the Commodity Futures Trading Commission (CFTC) issued its final rules for the phased implementation of mandatory clearing for interest rate swaps in

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact or view our subscription options here:

You are currently unable to copy this content. Please contact to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to View our subscription options

You need to sign in to use this feature. If you don’t have a account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here